<DOC>
	<DOCNO>NCT02726698</DOCNO>
	<brief_summary>The purpose study study clinical factor ( blood ) biomarkers related progression Atrial Fibrillation ( AF ) patient diagnose self-terminating AF special reference hypercoagulability . All patient continuously monitor atrial rhythm ass AF progression , either implantable loop recorder ( Reveal LinQ ) via atrial lead cardiac implantable electronic device ( CIED ) , combination CareLink home monitoring system . Remote monitor interrogation instal used daily basis .</brief_summary>
	<brief_title>Reappraisal Atrial Fibrillation : Interaction Between HyperCoagulability , Electrical Remodeling , Vascular Destabilisation Progression Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thrombophilia</mesh_term>
	<mesh_term>Atrial Remodeling</mesh_term>
	<criteria>New onset history paroxysmal , selfterminating AF document : AF ECG Holterrecording loop recorder Subclinical AF detect implantable cardiac device ( atrial read &gt; 190 beat per minute , last &gt; 6 minute ) . Prior history selfterminating AF allow ; Able willing sign inform consent registry ; Able willing undergo implantation implantable loop recorder ( patient without CIED ) ; In patient already oral anticoagulation drug , follow inclusion criterion need meet ( allow safe temporary interruption antithrombotic treatment coagulation phenotyping ) : CHA2DS2VASc score ≤5 ( history Congestive heart failure , Hypertension , Age ≥ 75 year ( double ) , Diabetes mellitus , Stroke/transient ischemic attack ( double ) , Vascular disease , Age 6575 year , female Sex ) ; No indication oral anticoagulation ( e.g . mechanical valve prosthesis ) ; Patient willing temporarily stop oral anticoagulation drug ( OAC ) . Nonselfterminating , persistent AF ; Deemed unsuitable willing undergo implantation loop recorder ( patient without CIED ) ; Refusing temporarily stop OAC coagulation phenotyping ( patient already OAC inclusion study ) ; On wait list pulmonary vein isolation expect placed wait list within one year ; Expected start amiodarone ; Pregnancy ; Life expectancy le 2.5 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>